Better cardiovascular care starts with better visibility, and too often, the right insights arrive too late.

In this episode, Marc Zemel, CEO of Retia Medical, shares the personal story that led him from engineering into medtech after losing his father to sudden cardiac arrest. He explains how Retia is rethinking cardiovascular monitoring by moving beyond bedside hardware into software-driven, distributed intelligence that leverages data hospitals already collect. Marc discusses the recent FDA clearance of Argos Infinity, Retia’s cardiovascular intelligence software platform, and how it expands access to advanced hemodynamic insight across operating rooms, ICUs, and tele-ICU environments. He also highlights why traditional monitoring models have been too limited, how earlier detection can reduce costly delays in care, and why hospitals now need technologies that help clinicians do more with fewer resources.

Tune in to learn how distributed cardiovascular intelligence could help clinicians detect deterioration earlier, improve outcomes, and reshape how critical care decisions are made!

Resources:

Connect with and follow Marc Zemel on LinkedIn.
Follow Retia Medical on LinkedIn and explore their website!
Read more about Argos Infinity and Retia’s recent FDA clearance here.